TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Mural Oncology Plc
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

Mural Oncology announced the final details of its acquisition by XRA 5 Corp., a subsidiary of XOMA Royalty, with a total cash consideration of $2.035 per share. The acquisition is expected to close in early December 2025, subject to Irish High Court sanction.

Insights
MURA   neutral

Being acquired at a predetermined price with no significant positive or negative indication of unexpected outcomes